Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 4:30 AM ET

Date/Time Source News Release
11/09/2022 04:00 PM EST GlobeNewswire Avalon GloboCare Announces NASDAQ Ticker Symbol Change from "AVCO" to "ALBT"
11/08/2022 09:10 AM EST GlobeNewswire Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million
10/19/2022 09:00 AM EDT Newsfile Avalon Globocare to Present at the LD Micro Main Event XV on October 26th
09/29/2022 09:00 AM EDT GlobeNewswire Avalon GloboCare Receives Allowance for Joint U.S. Patent
08/08/2022 09:00 AM EDT GlobeNewswire Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society
06/30/2022 09:00 AM EDT GlobeNewswire Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer
05/25/2022 09:00 AM EDT GlobeNewswire Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference
05/18/2022 09:00 AM EDT GlobeNewswire Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy
04/27/2022 09:00 AM EDT GlobeNewswire Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications
02/14/2022 09:00 AM EST GlobeNewswire Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
Page